The National Radium-223 Dichloride Audit Group: Data from Patients in 17 UK Oncology Centres with Metastatic Castrate-resistant Prostate Cancer Treated with Radium-223 Dichloride. Issue 2 (February 2019) - Randhawa, M.; Jones, R.; Stratton, I.; Bahl, A.; Bottomley, D.; Carruthers, H.